CL
59
3
HRL
35
12
TDC
83
-3
MET
64
-2
SWKS
57
7
CHD
37
2
REGN
57
-2
MDLZ
22
-16
BF.B
59
-2
VMC
57
-3
FDX
53
-2
GS
75
-5
PM
58
4
CHRW
73
-4
AAP
12
-14
WM
56
3
SWK
61
-3
JBHT
66
-3
FOX
70
-3
SYF
83
-7
CL
59
3
HRL
35
12
TDC
83
-3
MET
64
-2
SWKS
57
7
CHD
37
2
REGN
57
-2
MDLZ
22
-16
BF.B
59
-2
VMC
57
-3
FDX
53
-2
GS
75
-5
PM
58
4
CHRW
73
-4
AAP
12
-14
WM
56
3
SWK
61
-3
JBHT
66
-3
FOX
70
-3
SYF
83
-7
Financhill
Back

The Glimpse Group, Inc. Vs. MiNK Therapeutics, Inc. Industry Stock Comparison

Sell
22

VRAR
The Glimpse Group, Inc.

Last Price:
$0.96
Seasonality Move:
-0.01%
Sell
39

INKT
MiNK Therapeutics, Inc.

Last Price:
$12.15
Seasonality Move:
-18.07%
Sell
22
The Glimpse Group, Inc. (VRAR) is a Sell

Is The Glimpse Group, Inc. a Buy, Sell or Hold?

  • The current The Glimpse Group, Inc. [VRAR] share price is $1.02. The Score for VRAR is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • VRAR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
MiNK Therapeutics, Inc. (INKT) is a Sell

Is MiNK Therapeutics, Inc. a Buy, Sell or Hold?

  • The current MiNK Therapeutics, Inc. [INKT] share price is $12.42. The Score for INKT is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • INKT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VRAR Stock Price Chart

What is The Glimpse Group, Inc.'s stock price today?

  • The The Glimpse Group, Inc. share price today is $1.02
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRAR is experiencing selling pressure, which indicates risk of future bearish movement.

INKT Stock Price Chart

What is MiNK Therapeutics, Inc.'s stock price today?

  • The MiNK Therapeutics, Inc. share price today is $12.42
    The current trend is relatively stagnant and INKT is experiencing slight selling pressure.

VRAR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.08 Sell
Relative Strength Index (14 RSI): 38.47 Sell
Chaikin Money Flow: -111169 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.03 - 1.25) Sell
Bollinger Bands (100): (1.22 - 1.62) Sell

INKT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.15 Sell
Relative Strength Index (14 RSI): 51.41 Buy
Chaikin Money Flow: -4658 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.9 - 13.02) Buy
Bollinger Bands (100): (12.31 - 15.67) Sell

VRAR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.08 Sell
20-day SMA: 1.1 Sell
50-day SMA: 1.35 Sell
200-day SMA: 1.36 Sell
8-day EMA: 1.08 Sell
20-day EMA: 1.14 Sell
50-day EMA: 1.28 Sell
200-day EMA: 1.38 Sell

INKT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.19 Buy
20-day SMA: 11.57 Buy
50-day SMA: 13.1 Sell
200-day SMA: 11.81 Buy
8-day EMA: 12.21 Buy
20-day EMA: 12.1 Buy
50-day EMA: 12.78 Sell
200-day EMA: 12.24 Buy

The Glimpse Group, Inc. Earnings Growth & VRAR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

MiNK Therapeutics, Inc. Earnings Growth & INKT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.82 per share.

The Glimpse Group, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

MiNK Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):